1. DNA and protein engineering to create protein bioswitches with new functions Stewart Loh 2. Interaction and cross-talk of prelamin A with integral membrane zinc metalloproteases Susan Michaelis 3. An experimental protocol to study lipid transfer proteins Haijia Yu 4. Synthesis of small heat shock proteins Matthew Pratt 5. Druggable p-p interacting sites for Co-chaperone DNAJA1 and its partner proteins Guang-Yu Yang 6. An experimental protocol for glycoconjugate analysis Yifa Zhou 7. Methods for proximity-based biotinylation combined with Mass Spectrometry Ralph Kehlenbach 8. Synthetic antibody fragments as conformational sensors of protein activation and trafficking Arun K. Shukla 9. Expression, purification, functional analysis and crystallization of Rag GTPase Kuang Shen 10. Purification of bacterial transcription elongation complexes by photoreversible immobilization Eric Strobel 11. Inhibition of c-Myc-MAX heterodimerization Neha Garg 12. Fluorogenic RNA aptamers to probe transcription by multi-subunit RNA polymerases Markus C. Wahl 13. Phosphorylation and subcellular localization of human phospholipase A1 Atsushi Yamashita 14. Integrated methods in studying light-sensitive proteins Lars-Oliver Essen 15. Structure and biochemistry of thermophilic protein Ankan Banerjee 16. Using hydrogen/deuterium exchange mass spectrometry to probe protein structure Gert Bange 17. Nanopore force spectroscopy to probe structural dynamics of proteins Sonja Schmid 18. Structural analysis of knotted proteins Shang-Te "Danny" Hsu 19. Mutation-induced structural changes in the SARC-CoV2 spike protein Shang-Te "Danny" Hsu 20. Preparing metabolite capped RNA substrates using RNA polymerases Jeremy G. Bird
Dr. Arun K. Shukla is a world leader in the field of GPCR biology and he is currently a Professor in the Department of Biological Sciences and Bioengineering at the Institute of Technology, Kanpur in India. Dr. Shukla's research program is focused on understanding the structure, function and regulation of G protein-coupled receptors with a long-term of designing novel therapeutics with minimized side-effects.